The protective effect of increased CD4+ T-cell trafficking on the dynamics of HIV infection has been recently shown using another compartmental model (67), thus providing a basis for considering cell trafficking as an adjunct therapy option. This evidence concerns the gene CD4 and HIV infectious disease.